Literature DB >> 11447330

Down-regulation of the rat serotonin transporter upon exposure to a selective serotonin reuptake inhibitor.

S Horschitz1, R Hummerich, P Schloss.   

Abstract

The serotonin transporter (SERT) terminates serotonergic neurotransmission by rapid reuptake of 5-hydroxytryptamine (5-HT) into the nerve terminal or axonal varicosities. SERT represents the target of various antidepressants which inhibit 5-HT transport and are widely used for the pharmacotherapy of depression. Here, we have analyzed the function of SERT stably expressed in HEK 293 cells upon exposure to citalopram, a selective serotonin reuptake inhibitor (SSRI), with respect to 5-HT transport activity and protein expression as estimated by ligand binding experiments. Our results show that long-term exposure to an SSRI causes a down-regulation of transport activity as revealed by a reduction of the maximal transport rate, without affecting substrate affinity, accompanied by a decrease in ligand binding sites.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11447330     DOI: 10.1097/00001756-200107200-00027

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  10 in total

Review 1.  Ontogeny and regulation of the serotonin transporter: providing insights into human disorders.

Authors:  Lynette C Daws; Georgianna G Gould
Journal:  Pharmacol Ther       Date:  2011-04-05       Impact factor: 12.310

Review 2.  Serotonin transporters: implications for antidepressant drug development.

Authors:  Kellie J White; Crystal C Walline; Eric L Barker
Journal:  AAPS J       Date:  2005-10-05       Impact factor: 4.009

Review 3.  PharmGKB summary: citalopram pharmacokinetics pathway.

Authors:  Katrin Sangkuhl; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2011-11       Impact factor: 2.089

Review 4.  Neuroimaging research in human MDMA users: a review.

Authors:  Ronald L Cowan
Journal:  Psychopharmacology (Berl)       Date:  2006-07-18       Impact factor: 4.530

5.  The serotonin theory of depression: a systematic umbrella review of the evidence.

Authors:  Joanna Moncrieff; Ruth E Cooper; Tom Stockmann; Simone Amendola; Michael P Hengartner; Mark A Horowitz
Journal:  Mol Psychiatry       Date:  2022-07-20       Impact factor: 13.437

6.  Association of changes in norepinephrine and serotonin transporter expression with the long-term behavioral effects of antidepressant drugs.

Authors:  Zaorui Zhao; Han-Ting Zhang; Elianna Bootzin; Mark J Millan; James M O'Donnell
Journal:  Neuropsychopharmacology       Date:  2008-10-15       Impact factor: 7.853

7.  Biodistribution, toxicity and radiation dosimetry studies of the serotonin transporter radioligand 4-[18F]-ADAM in rats and monkeys.

Authors:  Ya-Yao Huang; Kuo-Hsing Ma; Ta-Wei Tseng; Ta-Kai Chou; Hanna Ng; Jon C Mirsalis; Ying-Kai Fu; Tieh-Chi Chu; Wen-Sheng Huang; Chyng-Yann Shiue
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-10-10       Impact factor: 9.236

8.  In vivo effect of antidepressants on [3H]paroxetine binding to serotonin transporters in rat brain.

Authors:  Subhash M Nadgir; Manish Malviya
Journal:  Neurochem Res       Date:  2008-04-25       Impact factor: 3.996

9.  The behavioral and neurochemical effects of an inescapable stressor are time of day dependent.

Authors:  Rachel A Daut; J Russell Ravenel; Linda R Watkins; Steven F Maier; Laura K Fonken
Journal:  Stress       Date:  2020-01-20       Impact factor: 3.493

10.  Toxicity and radiation dosimetry studies of the serotonin transporter radioligand [(18) F]AFM in rats and monkeys.

Authors:  Ya-Yao Huang; Chen-Yi Cheng; Wen-Sheng Huang; Kuo-Hsing Ma; Ta-Wei Tseng; Ta-Kai Chou; Yiyun Huang; Chyng-Yann Shiue
Journal:  EJNMMI Res       Date:  2014-12-29       Impact factor: 3.138

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.